title: Identification of new Gβγ interaction sites in adenylyl cyclase 2.
abstract: The role of Gβγ in adenylyl cyclase (AC) signaling is complicated due to its role as a conditional activator (AC2, AC4 and AC7) and an inhibitor (AC1, AC3 and AC8). AC2 is stimulated by Gα(s) and if Gβγ is present the stimulation is synergistic. The precise mechanism of this synergistic activation is still not known. In order to further elucidate the role of Gβγ in AC2 activation by Gα(s), peptides derived from the C1 domains of AC2 were synthesized and the ability of the various peptides to regulate AC2 function was tested. Our results identify two new Gβγ-binding sites in the AC2 C1 domain, AC2 C1a 339-360 and AC2 C1b 578-602 that are involved with stimulation of AC2 by Gβγ. These two regions are different from the previously described QEHA motif in the C2 domain of AC2. Further, the recently discovered PFAHL motif was confirmed to bind and to be involved with stimulation of AC2 by Gβγ. These functional studies indicate that multiple regions of AC2 are involved in the interaction with Gβγ.
authors: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.
authors: Aislyn D W
authors: AD
authors: Boran
authors: Yibang
authors: Y
authors: Chen
authors: Ravi
authors: R
authors: Iyengar
references: Adv Second Messenger Phosphoprotein Res. 1998;32:137-51
references: 9421589
references: Cell Signal. 2006 Jan;18(1):62-8
references: 15925485
references: Science. 1995 May 26;268(5214):1166-9
references: 7761832
references: Biochem J. 2008 Apr 15;411(2):449-56
references: 18215138
references: J Biol Chem. 1993 Jan 5;268(1):9-12
references: 8416978
references: J Biol Chem. 1997 Jul 25;272(30):19017-21
references: 9228084
references: FASEB J. 1998 Aug;12(11):1019-25
references: 9707174
references: J Biol Chem. 1991 May 5;266(13):8595-603
references: 2022671
references: Science. 1991 Dec 6;254(5037):1500-3
references: 1962211
references: Science. 1997 Dec 12;278(5345):1907-16
references: 9417641
references: J Biol Chem. 2007 Jan 5;282(1):294-302
references: 17110384
references: J Biol Chem. 2006 Jan 6;281(1):288-94
references: 16275644
references: Science. 1999 Jul 30;285(5428):756-60
references: 10427002
references: J Biol Chem. 1996 Oct 25;271(43):26445-8
references: 8900107
references: J Biol Chem. 1995 Sep 8;270(36):21368-73
references: 7673172
references: Curr Opin Cell Biol. 1993 Apr;5(2):269-73
references: 8507499
references: Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2648-52
references: 9482941
references: Biochemistry. 2005 Aug 9;44(31):10593-604
references: 16060668
references: Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10178-82
references: 1946437
references: Neuropharmacology. 2006 Jun;50(8):998-1005
references: 16545401
references: J Biol Chem. 1997 Feb 21;272(8):5040-7
references: 9030567
references: Biochemistry. 2001 Sep 11;40(36):10853-8
references: 11535062
references: Curr Opin Neurobiol. 1993 Jun;3(3):345-51
references: 8369627
references: J Biol Chem. 2001 Dec 7;276(49):45751-4
references: 11579096
references: J Mol Neurosci. 2005;27(2):195-203
references: 16186630
references: J Biol Chem. 1997 Aug 29;272(35):22265-71
references: 9268375
references: Mol Pharmacol. 1996 Jul;50(1):43-51
references: 8700117
references: Annu Rev Biochem. 1980;49:533-64
references: 6105841
references: FASEB J. 1993 Jun;7(9):768-75
references: 8330684
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2711-4
references: 9122261
references: J Biol Chem. 1995 Jan 6;270(1):1-4
references: 7814360
references: J Biol Chem. 1996 Aug 30;271(35):21309-15
references: 8702909